Method for diagnosing prostate cancer
CA 2500861 A1 · Owner: Oncotherapy Science, Inc. · Inventors: Nakagawa, Hidewaki; Nakatsuru, Shuichi; Nakamura, Yusuke
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Objective methods for detecting and diagnosing prostate cancer (PRC) or prostatic intraepithelial neoplasia (PIN) are described herein. In one embodiment, the diagnostic method involves the determining a expression level of PRC -associated gene that discriminate between PRC or PIN and nomal cell. The present invention further provides methods of screening for therapeutic agents useful in the treatment of either or both of PRC and PIN methods of , treating either or both of PRC and PIN and method of vaccinating a subject against either or both of PRC and PIN.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 22, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 22, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 22, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.